Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
Mallinckrodt
AstraZeneca
Baxter
Johnson and Johnson
Merck

Last Updated: January 26, 2020

DrugPatentWatch Database Preview

Patent: 7,064,248

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Summary for Patent: 7,064,248
Title:Method of preparing fertile transgenic corn plants by microprojectile bombardment
Abstract: A method of preparing fertile transgenic Zea mays (corn) plants which stably express DNA encoding a Bacillus thuringiensis endotoxin, so as to impart insect resistance to the fertile transgenic plants is taught. The method comprises bombarding regenerable corn cells with DNA-coated microprojectiles, wherein the DNA is adjusted to be more efficiently expressed in corn than the native B. thuringiensis sequence, and regenerating a fertile transgenic plants from the transformed cells.
Inventor(s): Lundquist; Ronald C. (Minnetonka, MN), Walters; David A. (Bloomington, MN), Kirihara; Julie A. (Bloomington, MN)
Assignee: DeKalb Genetics Corp. (DeKalb, IL)
Application Number:09/818,921
Patent Claims:see list of patent claims

Details for Patent 7,064,248

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Start Trial DeKalb Genetics Corp. (DeKalb, IL) 2010-01-22 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Start Trial DeKalb Genetics Corp. (DeKalb, IL) 2010-01-22 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial DeKalb Genetics Corp. (DeKalb, IL) 2010-01-22 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

International Patent Family for US Patent 7,064,248

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Dow
Mallinckrodt
McKinsey
Johnson and Johnson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.